Spectra Energy Partners LP (SEP) 44.46 $SEP Westcoast

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Spectra Energy Partners LP (SEP) 44.46 $SEP

Westcoast Energy Declares Dividends
CNW Group - Fri Sep 09, 2:54PM CDT
On September 9, 2016, Westcoast Energy Inc. declared the following quarterly dividends:
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Enbridge and Spectra Energy to Combine to Create North America's Premier Energy Infrastructure Company with C$165 Billion Enterprise Value
Marketwire Canada - Tue Sep 06, 5:31AM CDT
Transaction creates increased scale, asset diversity, financial flexibility and an industry leading secured project portfolio and development project inventory
SE: 42.31 (-0.17), ENB.TO: 57.55 (+0.11), SEP: 44.46 (+0.03), ENB: 43.70 (-0.29)

Spectra Energy CFO Pat Reddy to Speak at Goldman Sachs Power, Utilities, MLP and Pipeline Conference
PR Newswire - Tue Aug 09, 1:40PM CDT
Spectra Energy Corp (NYSE: SE) Chief Financial Officer Pat Reddy will speak at the 2016 Goldman Sachs Power, Utilities, MLP and Pipeline Conference on Thursday, August 11, 2016. Reddy also serves as chief financial officer of Spectra Energy Partners (NYSE: SEP).
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Westcoast Energy and Union Gas Declare Dividends
CNW Group - Mon Aug 08, 2:23PM CDT
On August 8, 2016, Westcoast Energy Inc. declared the following quarterly dividends:
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Spectra Energy Completes Sale of Empress NGL Business to Plains Midstream Canada
CNW Group - Thu Aug 04, 12:06PM CDT
Spectra Energy Corp (NYSE: SE) today announced that its indirect subsidiary, Westcoast Energy Inc., has completed the previously announced sale of its ownership interests in Spectra Energy's Canadian natural gas liquids (NGL) business to Plains Midstream Canada ULC, for a cash purchase price of approximately C$267 million (USD $204 million), including approximately C$67 million (USD $51 million) for inventory and working capital.
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Spectra Energy Partners Reports Second Quarter 2016 Results
PR Newswire - Wed Aug 03, 5:35AM CDT
Spectra Energy Partners, LP (NYSE: SEP) today reported net income of $305 million, including net income from controlling interests of $287 million, for the second quarter ended June 30, 2016, with diluted earnings per limited partner unit of $0.71. The second quarter included a non-recurring special item of $6 million, which decreased diluted earnings per limited partner unit by $0.02.
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Spectra Energy Reports Second Quarter 2016 Results
PR Newswire - Wed Aug 03, 5:30AM CDT
Spectra Energy Corp (NYSE: SE) today reported net income of $221 million, including net income from controlling interests of $149 million, for the second quarter ended June 30, 2016, with diluted earnings per share of $0.21. The second quarter included non-recurring special items. After income taxes of $12 million, non-recurring special items decreased diluted earnings per share by $0.03.
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Spectra Energy Partners Announces 35th Consecutive Quarterly Cash Distribution Increase
PR Newswire - Wed Aug 03, 5:25AM CDT
Spectra Energy Partners, LP (NYSE: SEP) announced that the board of directors of its general partner declared a quarterly cash distribution to unitholders of $0.66375 per unit, an increase of 1.25 cents over the previous level of $0.65125 per unit. This is the 35th consecutive quarter that Spectra Energy Partners has increased its quarterly cash distribution. The cash distribution is payable on August 26, 2016, to unitholders of record at the close of business on August 15, 2016. This quarterly cash distribution equates to $2.655 per unit on an annual basis.
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Spectra Energy Partners' Bill Yardley to Speak at 2016 MLPA Investor Conference
PR Newswire - Tue May 31, 10:15AM CDT
Spectra Energy Partners' (NYSE: SEP) Bill Yardley will speak at the Master Limited Partnership Association (MLPA) 2016 Investor Conference on Thursday, June 2, 2016. Yardley is president of U.S. Transmission and Storage for Spectra Energy Corp (NYSE: SE), the general partner of Spectra Energy Partners.
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

How Can Investors Benefit From These Oil And Gas Stocks? - ONEOK Partners, Crestwood Equity Partners, Shell Midstream Partners, and Spectra Energy Partners
PR Newswire - Fri May 20, 7:25AM CDT
Numerous challenges continue to press firms in the Oil and Gas Pipelines space, but many investors still see value in this industry. This morning, ActiveWallSt.com has its eyes focused on these equities: ONEOK Partners L.P. (NYSE: OKS), Crestwood Equity Partners L.P. (NYSE: CEQP), Shell Midstream Partners L.P. (NYSE: SHLX), and Spectra Energy Partners L.P. (NYSE: SEP). Sign up today to access the trading alerts by clicking below:
CEQP: 20.72 (-0.11), SHLX: 31.11 (+0.56), SE: 42.31 (-0.17), OKE: 48.62 (-1.02), SEP: 44.46 (+0.03), OKS: 38.65 (-0.61)

Spectra Energy Selects 2016 Scholarship Recipients
PR Newswire - Mon May 16, 1:10PM CDT
Spectra Energy Corp (NYSE: SE) today announced that 10 children of company employees have been selected to receive up to $5,000 per year in scholarship funds toward undergraduate study at an accredited college or university in the U.S. or Canada.
SE: 42.31 (-0.17), SEP: 44.46 (+0.03)

Spectra Energy's Earnings Remain Steady While It Awaits Completion of Its Major Projects
Tyler Crowe, The Motley Fool - Motley Fool - Thu May 05, 9:23AM CDT
Image source: Spectra Energy via Flickr. The theme of 2016 for investors in Spectra Energy will be patience. After completing more than $10 billion in projects over the past five years, there's going to be a noticeable lull in growth this year...
SE: 42.31 (-0.17), DPM: 34.51 (+0.08), SEP: 44.46 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading